X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6) 6
hematology (3) 3
humans (3) 3
isocitrate dehydrogenase - genetics (3) 3
aml (2) 2
cells (2) 2
differentiation (2) 2
inhibition (2) 2
leukemia, myeloid, acute - genetics (2) 2
medical research (2) 2
medicine, experimental (2) 2
mutant idh1 (2) 2
mutation (2) 2
-2-hydroxyglutarate (1) 1
15-year follow-up (1) 1
2-hydroxyglutarate (1) 1
abridged index medicus (1) 1
acute myeloid-leukemia (1) 1
adults (1) 1
age factors (1) 1
aged (1) 1
allogeneic (1) 1
anatomy & morphology (1) 1
animals (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
asparaginase (1) 1
azacitidine (1) 1
azacitidine - analogs & derivatives (1) 1
azacitidine - therapeutic use (1) 1
biochemical phenomena (1) 1
blood (1) 1
blood proteins (1) 1
chemotherapy (1) 1
cytokines (1) 1
decitabine (1) 1
diagnosis (1) 1
diffuse large b‐cell lymphoma (1) 1
disease (1) 1
dna modification methylases - antagonists & inhibitors (1) 1
epigenesis, genetic (1) 1
establishment (1) 1
european group (1) 1
female (1) 1
genotype (1) 1
gliomas (1) 1
glutamine (1) 1
glutarates - analysis (1) 1
glutarates - metabolism (1) 1
hematology, oncology and palliative medicine (1) 1
high‐grade b‐cell lymphoma (1) 1
hypomethylating agents (1) 1
idh1 mutations (1) 1
idh2 mutations (1) 1
immunohistochemistry (1) 1
immunohistochemistry - standards (1) 1
intensive chemotherapy (1) 1
isocitrate dehydrogenase (1) 1
isocitrate dehydrogenase mutations (1) 1
leukemia, myeloid, acute - diagnosis (1) 1
leukemia, myeloid, acute - drug therapy (1) 1
leukemia, myeloid, acute - pathology (1) 1
magnetic resonance spectroscopy (1) 1
magnetic-resonance-spectroscopy (1) 1
male (1) 1
mantle cell lymphoma (1) 1
marrow-transplantation (1) 1
mass spectrometry - standards (1) 1
medical laboratory technology (1) 1
multicenter (1) 1
mutation - genetics (1) 1
myelodysplastic syndromes (1) 1
neoplasms - enzymology (1) 1
neoplasms - genetics (1) 1
neoplasms - physiopathology (1) 1
odds ratio (1) 1
older patients (1) 1
oncology (1) 1
pathology (1) 1
prognosis (1) 1
prognostic impact (1) 1
reduced-intensity (1) 1
relapsed/refractory (1) 1
remission induction (1) 1
retrospective studies (1) 1
salvage therapy (1) 1
sequence analysis, dna - standards (1) 1
sex factors (1) 1
survival (1) 1
t cells (1) 1
therapy (1) 1
transplantation (1) 1
update (1) 1
versus-host-disease (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4773 - 4773
Introduction: Allogeneic hematopoietic cell transplant (allo-HCT) is a curative treatment option for patients with acute lymphoblastic leukemia (ALL). Both... 
Journal Article
Seminars in Hematology, ISSN 0037-1963, 07/2015, Volume 52, Issue 3, pp. 165 - 171
Acute myeloid leukemia (AML) is a lethal hematologic malignancy associated with poor clinical outcomes. In recent years, mutations in the IDH1 and IDH2 genes... 
HYPOMETHYLATING AGENTS | CELLS | PROGNOSTIC IMPACT | ASPARAGINASE | INHIBITION | GLUTAMINE | MUTANT IDH1 | DISEASE | DIFFERENTIATION | ISOCITRATE DEHYDROGENASE MUTATIONS | HEMATOLOGY | Animals | Epigenesis, Genetic | Humans | Isocitrate Dehydrogenase - genetics | Biochemical Phenomena | Mutation | Leukemia, Myeloid, Acute - genetics
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2019, Volume 30, Issue Supplement_6
Abstract Background A cytokine release syndrome (CRS) or neurotoxicity described as a chimeric antigen receptor (CAR) T Related Encephalopathy Syndrome (CRES)... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 95 - 95
Abstract Introduction: One of the main complications of adoptive T cell therapy (ACT) is the en-masse activation of tumor-reactive T cells inducing a large... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. 7014 - 7014
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 2885 - 2885
Introduction: Approximately 60% of Large B cell Lymphoma (LBCL) patients that receive CD19 CAR T cell therapy with axicabtagene ciloleucel (axi-cel) experience... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 4105 - 4105
Introduction: Of patients receiving CD19 CAR T cell therapy for large B cell lymphoma (LBCL), approximately 1 in 10 experience severe cytokine release syndrome... 
Journal Article
British journal of haematology, ISSN 0007-1048, 12/2019
While patients with double-hit lymphoma (DHL) are now frequently treated with intensive front-line immunochemotherapy, outcomes for those who fail these... 
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 03/2019, Volume 25, Issue 3, pp. S408 - S409
One of the main complications of adoptive T cell therapy (ACT) is the en-masse activation of tumor-reactive T cells leading to adverse events. These are... 
Medicine, Experimental | Medical research | Cytokines | T cells | Blood proteins
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 01/2019, Volume 60, Issue 2, pp. 309 - 316
Allogeneic hematopoietic cell transplantation (allo-HCT) is the only curative treatment for mantle cell lymphoma (MCL). We retrospectively analyzed outcomes of... 
Allogeneic | mantle cell lymphoma | transplantation | SURVIVAL | 15-YEAR FOLLOW-UP | DIAGNOSIS | MULTICENTER | EUROPEAN GROUP | VERSUS-HOST-DISEASE | REDUCED-INTENSITY | ONCOLOGY | UPDATE | MARROW-TRANSPLANTATION | HEMATOLOGY | BLOOD
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.